SCHEMBL16149753

SCHEMBL16149753

OC1CC2(CCCC2)CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4687502 0.76 — —
SCHEMBL4687964 0.76 — —
SCHEMBL14108544 0.76 — —
SCHEMBL4689717 0.73 — —
SCHEMBL26091740 0.70 KDM4E (0.31) —
SCHEMBL14076846 0.69 — —
SCHEMBL24827972 0.65 — —
SCHEMBL16151075 0.65 — —
SCHEMBL16659534 0.65 — —
SCHEMBL15801468 0.64 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016183150-A1 NOVEL SIGMA-2 RECEPTOR BINDERS AND THEIR METHOD OF USE TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2016-11-17 — — WO disclosed
EP-2970223-A1 NOVEL 5-HYDROXYTRYPTAMINE RECEPTOR 7 ACTIVITY MODULATORS AND THEIR METHOD OF USE Temple University Of The Commonwealth System Of Higher Education (US) 2016-01-20 — — EP disclosed
WO-2014164756-A1 NOVEL 5-HYDROXYTRYPTAMINE RECEPTOR 7 ACTIVITY MODULATORS AND THEIR METHOD OF USE TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2014-10-09 — — WO disclosed
Send feedback